🇺🇸 FDA
Patent

US 8673858

Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 8673858 (Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda) held by Soricimed Biopharma Inc. expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Soricimed Biopharma Inc.
Grant date
Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K38/1709, A61P, A61P17/00